Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Can commercial automated immunoassays be utilized to predict neutralizing antibodies after SARS-CoV-2 infection? A comparative study between three different assays.
Ismail A, Shurrab FM, Al-Jighefee HT, Al-Sadeq DW, Qotba H, Al-Shaar IA, Yassine HM, Abu-Raddad LJ, Nasrallah GK. Ismail A, et al. Among authors: al jighefee ht. Front Biosci (Landmark Ed). 2021 Jul 30;26(7):198-206. doi: 10.52586/4934. Front Biosci (Landmark Ed). 2021. PMID: 34340267 Free article.
Performance evaluation of five ELISA kits for detecting anti-SARS-COV-2 IgG antibodies.
Yassine HM, Al-Jighefee H, Al-Sadeq DW, Dargham SR, Younes SN, Shurrab F, Marei RM, Hssain AA, Taleb S, Alhussain H, Al-Nesf MA, Al-Khal A, Qotba H, Althani AA, Tang P, Abu-Raddad LJ, Nasrallah GK. Yassine HM, et al. Among authors: al jighefee h. Int J Infect Dis. 2021 Jan;102:181-187. doi: 10.1016/j.ijid.2020.10.042. Epub 2020 Oct 27. Int J Infect Dis. 2021. PMID: 33127504 Free PMC article.
Analytic comparison between three high-throughput commercial SARS-CoV-2 antibody assays reveals minor discrepancies in a high-incidence population.
Nasrallah GK, Dargham SR, Shurrab F, Al-Sadeq DW, Al-Jighefee H, Chemaitelly H, Al Kanaani Z, Al Khal A, Al Kuwari E, Coyle P, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Rahim HFA, Yassine HM, Al Kuwari MG, Qotba H, Al Romaihi HE, Tang P, Bertollini R, Al-Thani MH, Althani AA, Abu-Raddad LJ. Nasrallah GK, et al. Among authors: al jighefee h. Sci Rep. 2021 Jun 4;11(1):11837. doi: 10.1038/s41598-021-91235-x. Sci Rep. 2021. PMID: 34088944 Free PMC article.
Epidemiology of SARS-CoV2 in Qatar's primary care population aged 10 years and above.
Syed MA, Al Nuaimi AS, A/Qotba HA, Nasrallah GK, Althani AA, Yassine HM, Zainel AA, Khudadad H, Marji T, Veettil ST, Al-Jighefee HT, Younes S, Shurrab F, Al-Sadeq DW, AlFehaidi AAS, Yfakhroo AI, AlMesaifri MA, Al Mujalli H, Al Abdulla SA, Al Kuwari MG, Azad FM, Al Malki BAM, Abdulmalik MA. Syed MA, et al. Among authors: al jighefee ht. BMC Infect Dis. 2021 Jul 5;21(1):645. doi: 10.1186/s12879-021-06251-z. BMC Infect Dis. 2021. PMID: 34225657 Free PMC article.
Diagnostic Efficiency of Three Fully Automated Serology Assays and Their Correlation with a Novel Surrogate Virus Neutralization Test in Symptomatic and Asymptomatic SARS-COV-2 Individuals.
Younes S, Al-Jighefee H, Shurrab F, Al-Sadeq DW, Younes N, Dargham SR, Al-Dewik N, Qotba H, Syed M, Alnuaimi A, Yassine HM, Tang P, Abu-Raddad LJ, Nasrallah GK. Younes S, et al. Among authors: al jighefee h. Microorganisms. 2021 Jan 25;9(2):245. doi: 10.3390/microorganisms9020245. Microorganisms. 2021. PMID: 33504067 Free PMC article.
COVID-19 Vaccine Platforms: Challenges and Safety Contemplations.
Al-Jighefee HT, Najjar H, Ahmed MN, Qush A, Awwad S, Kamareddine L. Al-Jighefee HT, et al. Vaccines (Basel). 2021 Oct 18;9(10):1196. doi: 10.3390/vaccines9101196. Vaccines (Basel). 2021. PMID: 34696306 Free PMC article. Review.
12 results